Research Associate, Formulation Development
Elektrofi
Summary
Halozyme Hypercon is seeking a motivated Research Associate to support development of its ultra-high concentration microparticle suspension formulation platform. This laboratory-based role focuses on hands-on formulation studies and collaboration with multidisciplinary scientists, engineers, and industry professionals to solve complex technical challenges using innovative technologies.
Job description
In This Role, You'll Have The Opportunity To
- Execute stability and forced degradation studies, including sample preparation, scheduled testing, product characterization, and data capture.
- Conduct formulation screening and optimization studies for monoclonal antibodies and other biologic modalities by preparing formulations that assess relevant compositional and processing parameters.
- Operate and maintain laboratory equipment in accordance with approved procedures and escalate unexpected observations or trends to senior team members in a timely manner.
- Maintain complete, accurate, and contemporaneous records in electronic laboratory notebooks, databases, and other development documentation as per established procedures.
- Collaborate with analytical development, process development, device, and other partner functions to coordinate samples, methods, data, and study deliverables.
- Manage assigned tasks and timelines across one or more studies while demonstrating reliability, attention to detail, scientific curiosity, and a willingness to learn.
- Other duties as assigned
Requirements
- Bachelor's degree in Pharmaceutical Sciences, Chemical Engineering, Biochemistry, Biology, or a related field
- 0+ years of experience
- Knowledge of protein formulations and degradation mechanisms is desirable
- Hands-on experience with mAb formulation, tangential flow filtration (TFF) of protein solutions and aseptic handling techniques is desirable
- Familiarity with standard office software (MS Office, Teams, SharePoint, JMP) and electronic laboratory notebooks
- Demonstrated good laboratory skills, organizational skills, and attention to detail
- Ability to work in multi-disciplinary teams
Benefits
- Employee Stock Purchase Program
- 401(k) Matching
- Tuition Reimbursement
- Learning And Development Programs
- Career Progression Opportunities
Company overview
Elektrofi is a Boston-based biopharmaceutical formulation technology company founded in 2016 that is revolutionizing the delivery of biologic therapies. Its breakthrough hyper-concentration microparticle technology platform, Hypercon™, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large-molecule drugs, Elektrofi creates, develops, and commercializes subcutaneous biologic therapies in collaboration with strategic partners. The company has raised approximately $154 million in funding, including an oversubscribed $112.25 million Series C round in 2024 to establish commercial-scale GMP manufacturing capacity and accelerate clinical development. Elektrofi has partnered with major pharmaceutical companies such as Vertex Pharmaceuticals and SCHOTT Pharma. In 2025, Halozyme Therapeutics announced an agreement to acquire Elektrofi, combining two subcutaneous drug delivery specialists. Elektrofi employs roughly 39 people and operates globally from its headquarters in Boston, Massachusetts.